BeStock  
Stocks › Biotechnology › DYN

Dyne Therapeutics DYN

US equityMarket cap rank #2457Biotechnology
$15.50 −$0.53 (-3.31%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $15.50 0.00%
Open$15.91
Prev close$16.03
Day range$15.41 – $16.48
Volume2.23M
Market cap$2.90B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-4.7x
CheapRich

Below its usual level · 38th percentile, 5-year average -4.7x

Price / book3.5x
CheapRich

Around its usual level · 59th percentile, 5-year average 4.2x

#3936 of 5330 stocks by PB (1 = cheapest)

P/E over five years

-14x-9x-5x0xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$32.07
Price vs. fair value-51.7%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.45 – 4.18 59% (pricier than usual) #3936 of 5330 (1 = cheapest)
PE -4.74 -4.22 -4.67 38% (cheaper than usual) –
PS – 122.07 0.01 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on DYN.

Sign in to join the discussion.

Scroll to Top